Ascentage Pharma Group International American Depository Shares (AAPG) vs Kardigan (KARD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Ascentage Pharma Group International American Depository Shares is the larger company by market cap ($1.38 billion vs $1.37 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AAPG | KARD |
|---|---|---|
| Share price | $14.75 | $14.67 |
| Market cap | $1.38B | $1.37B |
| 1-day change | +1.37% | +3.31% |
| YTD return | -44.55% | — |
| 1-year return | -63.83% | — |
| EPS (TTM) | $-2.26 | $-10.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $37.50 | $27.00 |
| 52-week low | $14.46 | $12.23 |
| Distance from 52-week high | -60.67% | -45.67% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +219.53% | +188.00% |
| Average volume | 6.37K | 487.54K |
| Shares outstanding | 93.39M | 93.50M |
| Employees | 828 | 241 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Ascentage Pharma Group International American Depository Shares
AAPG stock →Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation.
Health Care · Biotechnology: Pharmaceutical Preparations · 828 employees
About Kardigan
KARD stock →Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 241 employees
AAPG vs KARD FAQ
Which is bigger, Ascentage Pharma Group International American Depository Shares or Kardigan?
Ascentage Pharma Group International American Depository Shares (AAPG) is larger, with a market capitalization of $1.38B compared with $1.37B for Kardigan (KARD).
Are Ascentage Pharma Group International American Depository Shares and Kardigan in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.